메뉴 건너뛰기




Volumn 54, Issue SUPL., 2006, Pages 15-18

Cytokine network and its manipulation in rheumatoid arthritis

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

EID: 33750588192     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (13)
  • 2
    • 0035932519 scopus 로고    scopus 로고
    • Cytokine pathways and joint inflammation in rheumatoid arthritis
    • Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-16.
    • (2001) N Engl J Med , vol.344 , pp. 907-916
    • Choy, E.H.1    Panayi, G.S.2
  • 3
    • 0035056003 scopus 로고    scopus 로고
    • Anti-TNF-α therapy of rheumatoid arthritis: What have we learned?
    • Feldmann M., Maini RN. Anti-TNF-α therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 2001;19:163-96.
    • (2001) Annu Rev Immunol , vol.19 , pp. 163-196
    • Feldmann, M.1    Maini, R.N.2
  • 4
    • 0035068522 scopus 로고    scopus 로고
    • Physiology of cytokine pathways in rheumatoid arthritis
    • Arend WP. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 2001;45:101-6.
    • (2001) Arthritis Rheum , vol.45 , pp. 101-106
    • Arend, W.P.1
  • 5
    • 0034232080 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha blockade: A new era for effective management of rheumatoid arthritis
    • Hamilton K, Clair EW. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis. Expert Opin Pharmacother 2000;1:1041-52.
    • (2000) Expert Opin Pharmacother , vol.1 , pp. 1041-1052
    • Hamilton, K.1    Clair, E.W.2
  • 6
    • 0032692402 scopus 로고    scopus 로고
    • The role of cytokines in the pathogenesis of rheumatoid arthritis
    • Feldmann M, Maini RN. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology 1999;38 (supl. 2):3-7.
    • (1999) Rheumatology , vol.38 , Issue.SUPL. 2 , pp. 3-7
    • Feldmann, M.1    Maini, R.N.2
  • 7
    • 34247481110 scopus 로고    scopus 로고
    • mr1214.01-01.html OR http://www.medscape.com/UpToDate/2000/utd0701.01.rheum/ utd0701.01.rheum-01.html
    • Strand V. Anticytokine therapies in rheumatoid arthritis. http://www.medscape.com/Medscape/Rheumatology/journal/1999/v01.n12/mr1214.01/ mr1214.01-01.html OR http://www.medscape.com/UpToDate/2000/utd0701.01.rheum/ utd0701.01.rheum-01.html
    • Anticytokine therapies in rheumatoid arthritis
    • Strand, V.1
  • 9
    • 34247473156 scopus 로고    scopus 로고
    • Misra R. Biological response modifiers in rheumatoid arthritis. In: Rheumatoid Arthritis Ed. Das SK. (Technical Series) ICP-API; 2001:73-4.
    • Misra R. Biological response modifiers in rheumatoid arthritis. In: Rheumatoid Arthritis Ed. Das SK. (Technical Series) ICP-API; 2001:73-4.
  • 11
    • 0034735839 scopus 로고    scopus 로고
    • Biologic therapy for rheumatoid arthritis
    • Klippel JH. Biologic therapy for rheumatoid arthritis. N Engl J Med 2000;343:1640-1.
    • (2000) N Engl J Med , vol.343 , pp. 1640-1641
    • Klippel, J.H.1
  • 12
    • 0034735842 scopus 로고    scopus 로고
    • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
    • Lipsky PE, van der Heijde DM. St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000;343:1594-602.
    • (2000) N Engl J Med , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    van der Heijde, D.M.2    St. Clair, E.W.3    Furst, D.E.4    Breedveld, F.C.5    Kalden, J.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.